The determinants and scope of public health interventions to tackle the global problem of hypertension

International Journal of Preventive Medicine

Volumn 5, Issue 7, 2014, Pages 807-812

  Shrivastava, Saurabh RamBihariLal ^a   Shrivastava, Prateek Saurabh ^a   Ramasamy, Jegadeesh ^a  

^a Sri Balaji Vidyapeeth Deemed to Be University   (India)

Author keywords

Cardiovascular disease; Hypertension; Public health

Indexed keywords

AWARENESS; CARDIOVASCULAR RISK; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; OUTCOME ASSESSMENT; PREVALENCE; PUBLIC HEALTH PROBLEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL DETERMINANTS OF HEALTH;

EID: 84904161550     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. World Health Organization. Cardiovascular diseases-Fact sheet N°317, 2013. Available from: http://www.who. int/mediacentre/factsheets/fs317/en/. [Last accessed on 2013 Nov 19].
2. Mackay J, Mensah GA. The atlas of heart disease and stroke, World Health Organization and Center for Disease Control and Prevention. Available from: http://www. who.int/cardiovascular_diseases/resources/atlas/en/. [Last accessed on 2013 Oct 22].
3. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in mozambique: Urban/rural gap during epidemiological transition. Hypertension 2009;54:77-83.
4. World Health Organization. World Health Day 2013: Calls for intensified efforts to prevent and control hypertension. Available from: http://www.who.int/workforcealliance/media/news/2013/whd2013story/en/ index.html. [Last accessed on 2013 Nov 14].
5. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008;52:818-27.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.
7. Georgiopoulou VV, Kalogeropoulos AP, Butler J. Heart failure in hypertension: Prevention and treatment. Drugs 2012;72:1373-98.
8. Barylski M, Małyszko J, Rysz J, Myśliwiec M, Banach M. Lipids, blood pressure, kidney-what was new in 2011? Arch Med Sci 2011;7:1055-66.
9. Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep 2011;5:174-9.
10. Israili ZH, Hernández-Hernández R, Valasco M. The future of antihypertensive treatment. Am J Ther 2007;14:121-34.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
13. Szczech LA, Lazar IL. Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD. Kidney Int 2004;90:S3-7.
14. Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004;26:731-8.
15. Doǧan N, Toprak D, Demir S. Hypertension prevalence and risk factors among adult population in Afyonkarahisar region: A cross-sectional research. Anadolu Kardiyol Derg 2012;12:47-52.
16. Jaddou HY, Batieha AM, Khader YS, Kanaan AH, El-Khateeb MS, Ajlouni KM. Hypertension prevalence, awareness, treatment and control, and associated factors: Results from a national survey, Jordan. Int J Hypertens 2011;2011:828797.
17. Al-Nozha MM, Abdullah M, Arafah MR, Khalil MZ, Khan NB, Al-Mazrou YY, et al. Hypertension in Saudi Arabia. Saudi Med J 2007;28:77-84.
18. Janus ED, Bunker SJ, Kilkkinen A, McNamara K, Philpot B, Tideman P, et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the greater green triangle risk factor study 2004-2006. Intern Med J 2008;38:879-86.
19. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: The Ansan study. J Hypertens 2001;19:1523-32.
20. Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 2005;365:493-500.
21. Cipullo JP, Martin JF, Ciorlia LA, Godoy MR, Caçao JC, Loureiro AA, et al. Hypertension prevalence and risk factors in a Brazilian urban population. Arq Bras Cardiol 2010;94:519-26.
22. Min H, Chang J, Balkrishnan R. Socio-demographic risk factors of diabetes and hypertension prevalence in republic of Korea. Int J Hypertens 2010;2010:410794.
23. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 2006;166:2348-55.
24. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997;87:160-8.
25. Bharati VM, Ajayi KS. Hypertension in the developing world: challenges and opportunities. American Journal of Kidney Diseases 2010;55:590-8.
26. Peters RM, Aroian KJ, Flack JM. African American culture and hypertension prevention. West J Nurs Res 2006;28:831-54.
27. Biino G, Parati G, Concas MP, Adamo M, Angius A, Vaccargiu S, et al. Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates. PLoS One 2013;8:e59612.
28. Ma WJ, Tang JL, Zhang YH, Xu YJ, Lin JY, Li JS, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens 2012;25:590-6.
29. Zhao Y, Lu F, Sun H, Liu Z, Zhao Y, Sun S, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in Shandong Province of China. J Clin Hypertens (Greenwich) 2012;14:637-43.
30. Perez-Fernandez R, Marino AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I, et al. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens 2007;21:366-73.
31. Krzysztoszek J, Wierzejska E, Paczkowska A, Ratajczak P. Health-related behaviours and hypertension prevention in Poland, An environmental study. Arch Med Sci 2013;9:218-29.
32. Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev 2002;3:147-56.
33. Liu L, Ikeda K, Chen M, Yin W, Mizushima S, Miki T, et al. Obesity, emerging risk in China: Trend of increasing prevalence of obesity and its association with hypertension and hypercholesterolaemia among the Chinese. Clin Exp Pharmacol Physiol 2004;31:S8-10.
34. Nkondjock A, Bizome E. Dietary patterns associated with hypertension prevalence in the Cameroon defence forces. Eur J Clin Nutr 2010;64:1014-21.
35. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. National high blood pressure education program coordinating committee, Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. JAMA 2002;288:1882-8.
36. Grynberg A. Hypertension prevention: From nutrients to (fortified) foods to dietary patterns Focus on fatty acids. J Hum Hypertens 2005;19:S25-33.
37. Horky K. Reducing food salt content: A neglected approach to hypertension prevention and treatment in the population. Vnitr Lek 2009:55:797-801.
38. Stamler J. The INTERSALT Study: Background, methods, findings, and implications. Am J Clin Nutr 1997;65:S626-42.
39. Peters RM, Flack JM. Salt-sensitivity and hypertension in African Americans: Implications for cardiovascular nurses. Progress in Cardiovascular Nursing 2001;15:138-44.
40. Campbell NR, Burgess E, Choi BC, Taylor G, Wilson E, Cleroux J, et al. Lifestyle modifications to prevent and control hypertension 1 Methods and an overview of the Canadian recommendations Canadian hypertension society, Canadian coalition for high blood pressure prevention and control, laboratory centre for disease control at health Canada, heart and stroke foundation of Canada. CMAJ 1999;160:S1-6.
41. Sempos CT, Rehm J, Wu T, Crespo CJ, Trevisan M. Average volume of alcohol consumption and all-cause mortality in African Americans: The NHEFS cohort. Alcohol Clin Exp Res 2003;27:88-92.
42. Centers for Disease Control. Cigarette smoking among adults-United States, 2002. MMWR 2004;53:427-31.
43. Crespo CJ, Smith E, Andersen RE, Carter-Pokras O, Ainsworth BE. Race/ethnicity, social class and their relation to physical inactivity during leisure time: Results from the third national health and nutrition examination survey, 1988-1994. American Journal of Preventive Medicine 2000;18:46-53.
44. Levy PD, Flack JM. Should African-Americans with elevated blood pressure be routinely screened for hypertensive heart disease? Expert Rev Cardiovasc Ther 2012;10:1201-4.
45. Peters RM. Racism and hypertension among African Americans. West J Nurs Res 2004;26:612-31.
46. Benkert R, Peters RM. African American women's coping with health care prejudice. West J Nurs Res 2005;27:863-89.
47. Plescia M, Groblewski M. A community-oriented primary care demonstration project: refining interventions for cardiovascular disease and diabetes. Ann Fam Med 2004;2:103-9.
48. Gettleman L, Winkleby MA. Using focus groups to develop a heart disease prevention program for ethnically diverse, low-income women. J Community Health 2000;25:439-53.
49. Aroian KJ, Peters RM, Rudner N, Waser L. Hypertension prevention beliefs of Hispanics. J Transcult Nurs 2012;23:134-42.
50. World Health Organization. Prevention of cardiovascular disease: Guidelines for assessment and management of cardiovascular risk. WHO Press: Geneva, 2007.
51. Prabhakaran D, Singh K. Premature coronary heart disease risk factors & reducing the CHD burden in India. Indian J Med Res 2011;134:8-9.
52. Shillinglaw B, Viera AJ, Edwards T, Simpson R, Sheridan SL. Use of global coronary heart disease risk assessment in practice: A cross-sectional survey of a sample of US physicians. BMC Health Serv Res 2012;12:20.
53. Campbell NR. Hypertension prevention and control in Canada. J Am Soc Hypertens 2008;2:97-105.
54. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003;42:878-84.
55. Huang WY, Davidge ST, Wu J. Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment. Crit Rev Food Sci Nutr 2013;53:615-30.